Vaccines
DHL Supply Chain is entrusted by GE Healthcare Japan
DHL Supply Chain (DHL), the global contract logistics leader, has opened five new logistics centers in Japan to support its operations for GE Healthcare Ja...
November 24, 2021 | News
Laos becomes the 20th country to authorize the one-shot Sputnik Light vaccine
Sputnik Light vaccine is based on human adenovirus serotype 26, which is the first component of the Sputnik V vaccine. In March 2021 the two-dose...
November 24, 2021 | News
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...
November 23, 2021 | News
Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
The parties have signed a binding term sheet, and a definitive agreement is in process and is expected to be executed within the next month pending standar...
November 09, 2021 | News
Novavax Files COVID-19 Vaccine for EU Listing with WHO
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...
November 05, 2021 | News
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe Novavax, Inc. (Nasdaq: NVAX), a biote...
November 04, 2021 | News
Novavax and Serum Institute of India Receive EUA for COVID-19 Vaccine in Indonesia
"The first authorization of Novavax' COVID-19 vaccine exemplifies our commitment to equitable global access and will fill a vital need for Indonesia, ...
November 02, 2021 | News
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia --...
November 01, 2021 | News
Why is the WHO delaying an EUL status to Covaxin?
The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...
October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."
Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity
Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the co...
October 29, 2021 | News
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom
All modules required for regulatory review, including CMC data, are now complete Submission based on Phase 3 data from ~45K patients demonstrating high ...
October 28, 2021 | News
Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines
The announcement by WHO, comes after the approval from WHO Ethics Review Committee and relevant regulatory authorities and ethics committees of&n...
October 27, 2021 | News
Korean Ginseng Research Institute Announces potential COVID-19 Vaccine Adjuvant Effect of Red Ginseng
The results of the study summarized this time showed that red ginseng increased the effectiveness of the vaccine, so that when red ginseng was taken togeth...
October 22, 2021 | News
Elixirgen Therapeutics Announces Licensing Agreement for Its Novel COVID-19 Vaccine
it has entered into an exclusive licensing agreement with a global pharmaceutical company (currently undisclosed) for the rights to commercialize its self-...
October 11, 2021 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
